TFRC and systemic lupus erythematosus: Our previous study [4] showed that the proportion of activated Tfr cells was decreased and negatively correlated with disease activity in patients with SLE and that IL-2 can restore the function of Tfr cells, not only directly expanding the activated Tfr cells but also indirectly converting Tfh to Tfr cells.